On June 10, 2025, Health Canada initiated a public consultation on proposed revisions to its Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs. A notable update is the proposal to remove...more
6/25/2025
/ Biologics ,
Biosimilars ,
Canada ,
Clinical Trials ,
Life Sciences ,
New Guidance ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Rules ,
Regulatory Oversight ,
Regulatory Reform
On May 5, 2025, the Ontario government introduced Bill 11, the proposed More Convenient Care Act, 2025 (“MCCA”), a legislative initiative aimed at supporting the province’s long-term healthcare goals for first reading. Bill...more
5/29/2025
/ Canada ,
Data Privacy ,
Digital Health ,
Health Care Providers ,
Healthcare ,
New Legislation ,
Patient Privacy Rights ,
Proposed Legislation ,
Regulatory Reform ,
Regulatory Requirements ,
Transparency
The Regulations Amending Certain Regulations Concerning the Disclosure of Cosmetic Ingredients (SOR/2024-63) (the “Amended Cosmetic Regulations), published on April 24, 2024, took effect on October 9th (with the exception of...more
10/17/2024
/ Canada ,
Consumer Product Companies ,
Cosmetics ,
Manufacturers ,
New Regulations ,
Personal Care Products ,
Popular ,
Product Labels ,
Public Health ,
Regulatory Reform ,
Retail Market